---
name: Scimega Research
slug: scimega
site: cro
website_domain: scimega.com
summary: Canadian oncology-focused CRO running Phase 1, 2 and 3 trials through privileged site relationships across Canada. Offers Reverse Feasibility, Health Canada CTA/IND strategy, provincial ethics approval support and CRA monitoring for small and mid-sized biopharma sponsors. Headquartered in Laval, Canada.
tagline: Canada's leading oncology-focused CRO since 1997
founded_year: 1997
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: CA
tier2_domain_verified: false
updated_at: 2026-11-22T11:01:15.270Z
services_count: 5
modalities_count: 0
indications_count: 1
locations_count: 1
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# Scimega Research

Canada's leading oncology-focused CRO since 1997

Listed on cro.directory.

## Summary

Canadian oncology-focused CRO running Phase 1, 2 and 3 trials through privileged site relationships across Canada. Offers Reverse Feasibility, Health Canada CTA/IND strategy, provincial ethics approval support and CRA monitoring for small and mid-sized biopharma sponsors. Headquartered in Laval, Canada.

## At a glance

- Founded: 1997
- HQ country: CA

## Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Clinical Operations
- Regulatory Affairs

## Indications

- Oncology

## Locations

- Laval, Laval, Québec, Canada

## Long description

## Oncology CRO for Canada

Scimega is a niche contract research organization founded in 1997 with a singular focus on oncology clinical trials in Canada. The company works with small and mid-sized biopharma sponsors and describes itself as Canada's leading oncology-focused CRO.

## Services

- **Site selection and accelerated study start-up**, including a Reverse Feasibility Program that connects sponsors with a network of Canadian oncology investigators.
- **Early development expertise (Phase 1 and 2)** in oncology.
- **Phase 3 oncology trial management** for large-scale pivotal studies.
- **Health Canada regulatory strategy**, covering CTA/IND regulatory strategy.
- **Provincial ethics approval strategy**, covering ethics board submission strategy.
- **Clinical monitoring services**, using CRAs with oncology experience.
- **Country oversight** of Canadian clinical operations.

## Differentiation

Scimega describes its privileged relationships with sites across Canada and states that it works with local, permanent clinical research associates and staff who focus on oncology. The company says it aims to shorten site start-up times by about 50% for its clients. Its stated approach is to integrate each trial plan and manage mitigation actions without adding administrative burden to sponsors.

## Similar companies

- [SMO India Clinical Research Pvt Ltd](/companies/smo-india) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/scimega/smo-india)
- [SciQuus Oncology](/companies/sciquus) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/scimega/sciquus)
- [Evanjo CRO](/companies/evanjo-cro) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/evanjo-cro/scimega)
- [Proxima Clinical Research](/companies/proximacro) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/proximacro/scimega)
- [Sacura GmbH](/companies/sacura-cro) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/sacura-cro/scimega)
- [SanaClis](/companies/sanaclis) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/sanaclis/scimega)
- [ERGOMED Group](/companies/ergomed) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/ergomed/scimega)
- [JSS Medical Research](/companies/jssresearch) (Phase I Clinical Trials, Phase II Clinical Trials) — [Compare](/compare/jssresearch/scimega)

_Profile last updated: 2026-11-22T11:01:15.270Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.